本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Sagimet Biosciences Inc.

3.59
-0.2400-6.27%
盘后3.590.00000.00%19:31 EDT
成交量:43.40万
成交额:155.17万
市值:1.16亿
市盈率:-2.47
高:3.79
开:3.79
低:3.50
收:3.83
数据加载中...
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/13

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/25

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/24

重要事件披露

Form 8-K - Current report
2024/01/24

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/24

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933